Sequent Scientific Limited (NSE:SEQUENT)
India flag India · Delayed Price · Currency is INR
148.12
-5.92 (-3.84%)
Apr 25, 2025, 3:30 PM IST

Sequent Scientific Company Description

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally.

The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology.

It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products.

The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009.

The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.

Sequent Scientific Limited
Country India
Founded 1985
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,195
CEO Rajaram Narayanan

Contact Details

Address:
Dosti Pinnacle
Mumbai, 400604
India
Phone 91 22 4111 4777
Website sequent.in

Stock Details

Ticker Symbol SEQUENT
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE807F01027
SIC Code 2834

Key Executives

Name Position
Rajaram Narayanan MD, Chief Executive Officer and Director
Saurav Bhala Chief Financial Officer
Phillip Trott Assoc. Vice President, Head of Legal and Chief Risk Officer
Ramesh Kumar Pillai Corporate Vice President of Ra Qa and Technical Services
Ravi Nair Executive Vice President of Human Resources and Administration
Abhishek Singhal Head of Investor Relations
Yoshita Vora Company Secretary and Compliance Officer
Vedprakash Ragate Executive Director
Prasad Lad Vice President of Human Resources and Administration